Akira Pharma Private Limited - Company Profile

Q: Who are the current directors of Akira Pharma Private Limited?

The current directors of Akira Pharma Private Limited are Gurpreet Sandhu Singh, Trilochan Singh Sandhu.

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2009.

2009 New Delhi, Delhi, India Active

Last Updated: January 08, 2026

About Akira Pharma Private Limited

Akira Pharma Private Limited, a active private limited company, was established on 17 November 2009 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51101DL2009PTC196057. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹2.41 M.

It upholds a compliant status. Its leadership includes Gurpreet Sandhu Singh (Director), Trilochan Singh Sandhu (Director). Past directors included Harshit Singh, Anuradha Sandhu. It holds ₹3.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-4 , Ground Floor , Part A, Village Mahipalpur, Main Vasant Kunj Road, Opp. Jagan Nath Complex, New Delhi, Delhi, 110037.

Company Details

CIN/LLPIN
U51101DL2009PTC196057
Registration Number
196057
Incorporation Date
17 November 2009
Authorized Capital
₹7.00 Cr
Paid-Up Capital
₹2.41 M
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 7.00 Cr as on 08-01-2026
Paid Up Capital ₹ 2.41 M as on 08-01-2026
Company Age 16 Year, 3 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 3.00 Cr as on 08-01-2026
Revenue Growth **** -7.73% (FY 2020)
Profit Growth **** 95.69% (FY 2020)
Ebitda **** 103.18% (FY 2020)
Net Worth -0.14% (FY 2020)
Total Assets -1.14% (FY 2020)

Comprehensive Company Insights

Explore comprehensive insights into Akira Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Akira Pharma Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Gurpreet Sandhu Singh	Director	17 Nov 2009	Current
Trilochan Singh Sandhu	Director	19 Aug 2013	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Company Secretary	30 Nov 2019	Past
Pramod Abcsdd	Director	20 Aug 2013	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Akira Pharma.

Akira Pharma Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 7.73% decrease. The company also saw a substantial improvement in profitability, with a 95.69% increase in profit. The company's net worth dipped by a decrease of 0.14%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-7.73%

*******

Revenue from Operations

*******

-7.40%

*******

Total Assets

*******

-1.14%

*******

Profit or Loss

*******

95.69%

*******

Net Worth

*******

-0.14%

*******

EBITDA

*******

103.18%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Akira Pharma?

In 2020, Akira Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹29,977,300.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 1.60 Cr
Others : 1.40 Cr

Latest Charge Details

Date	Lender	Amount	Status
14 Oct 2024	Hdfc Bank Limited	₹1.60 Cr	Open
23 Mar 2024	Others	₹1.40 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Akira Pharma?

Unlock and access historical data on people associated with Akira Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Akira Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akira Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Akira Pharma

Recent Activity within the Organization

Charges

Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.60 Cr with Charge ID 101022084 was registered on 14 Oct 2024. was documented.
14 Oct 2024
Annual General Meeting

Akira Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
30 Sep 2024
Balance Sheet

The activity Akira Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
31 Mar 2024
Charges

A charge with Others amounted to Rs. 1.40 Cr with Charge ID 100958317 was registered on 23 Mar 2024. was recorded as a recent event.
23 Mar 2024
Director Appointment

Progress on Trilochan Singh Sandhu was appointed as a Director was appointed as a Director on 19 Aug 2013 & has been associated with this company since 12 years 6 months . was documented.
19 Aug 2013
Director Appointment

The activity Gurpreet Sandhu Singh was appointed as a Director was appointed as a Director on 17 Nov 2009 & has been associated with this company since 16 years 3 months . was completed.
17 Nov 2009

Explore recent activity and updates - View Recent Activity